Literature DB >> 33511866

How we treat Merkel cell carcinoma: within and beyond current guidelines.

Song Y Park1, Coley Doolittle-Amieva1, Yasman Moshiri1, Tomoko Akaike1, Upendra Parvathaneni2, Shailender Bhatia3, Lisa C Zaba4, Paul Nghiem1,2.   

Abstract

Merkel cell carcinoma (MCC) is an aggressive skin cancer associated with a high risk of local recurrence and distant metastasis. Optimal care of this potentially life-threatening cancer is critical but challenging because: physicians are often unfamiliar with its management due to rarity, and MCC management remains controversial, in part because it is rapidly evolving across multiple specialties. While guidelines offer a broad overview of management, they are often not sufficient when making decisions for individual patients. Herein, we present a literature review as well as practical approaches adopted at our institutions for staging, surveillance and therapy of MCC. Each of these areas are discussed in light of how they can be appropriately customized for prevalent but challenging situations. We also provide representative examples of MCC patient scenarios and how they were managed by a multidisciplinary team to identify suitable evidence-based, individualized treatment plans.

Entities:  

Keywords:  Merkel cell carcinoma; customized treatment; imaging; immunotherapy; multidisciplinary management; radiotherapy; surgery; surveillance

Year:  2021        PMID: 33511866     DOI: 10.2217/fon-2020-1036

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  4 in total

Review 1.  [Human polyomavirus-associated skin diseases].

Authors:  Steffi Silling; Alexander Kreuter; Ulrike Wieland
Journal:  Hautarzt       Date:  2022-04-28       Impact factor: 0.751

Review 2.  Scientific and clinical developments in Merkel cell carcinoma: A polyomavirus-driven, often-lethal skin cancer.

Authors:  Tomoko Akaike; Paul Nghiem
Journal:  J Dermatol Sci       Date:  2021-10-18       Impact factor: 4.563

3.  Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel.

Authors:  Francesca Spada; Paolo Bossi; Corrado Caracò; Vanna Chiarion Sileni; Angelo Paolo Dei Tos; Nicola Fazio; Giovanni Grignani; Michele Maio; Pietro Quaglino; Paola Queirolo; Paolo Antonio Ascierto
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

4.  Merkel cell carcinoma can be indolent: A case with 7 locoregional recurrences over 15 years highlights the importance of patient-tailored management.

Authors:  Alyssa Breneman; Tomoko Akaike; Kelly G Paulson; Debra L Breneman; Paul Nghiem
Journal:  JAAD Case Rep       Date:  2021-08-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.